Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.25.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 129,758 $ 62,632
Equity method investments 3,612,394 2,966,305
Receivables, net of allowance of $50 million and $50 million, respectively 2,895,837 3,073,855
Receivables held-for-sale 75,556 35,299
Real estate 2,984 111,036
Investments 6,818 7,165
Securitization assets, net of allowance of $3 million and $3 million, respectively 248,688 218,946
Other assets 108,210 77,112
Total assets 7,080,245 6,552,350
Liabilities:    
Accounts payable, accrued expenses and other 275,639 163,305
Credit facilities 1,001 400,861
Commercial paper notes 100,057 30,196
Term loans payable 407,978 727,458
Senior unsecured notes 3,139,363 2,318,841
Convertible notes 619,543 609,608
Total Liabilities 4,675,170 4,410,725
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 118,960,353 and 112,174,279 shares issued and outstanding, respectively 1,190 1,122
Additional paid-in capital 2,592,964 2,381,510
Accumulated deficit (297,499) (303,536)
Accumulated other comprehensive income (loss) 40,101 13,165
Non-controlling interest 68,319 49,364
Total Stockholders’ Equity 2,405,075 2,141,625
Total Liabilities and Stockholders’ Equity 7,080,245 6,552,350
Non-recourse debt    
Liabilities:    
Non-recourse debt (secured by assets of $307 million and $239 million, respectively) $ 131,589 $ 160,456